Cargando…
LBSAT255 Real World Performance Of The Afirma Genomic Sequencing Classifier (GSC) - A Meta-analysis
The Afirma GSC aids in the clinical decision making for patients with indeterminate thyroid nodule cytology (ITN). The 2018 GSC validation study was a prospective, multi-center study, conducted on a patient cohort with ITN. All patients underwent surgery without known genomic information and were as...
Autores principales: | Nasr, Christian E, Andriol, Massimiliano, Endo, Mayumi, Mack Harrell, R, Livhits, Masha J, Osakwe, Ibitoro, Polavarapu, Preethi, Wei, Shuanzeng, Zheng, Xingyu, Jiang, Ruochen, Hao, Yangyang, Huang, JIng, Kloppe, Joshua P, Kloos, Richard T, Kennedy, Giulia, Angell, Trevor E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625157/ http://dx.doi.org/10.1210/jendso/bvac150.1538 |
Ejemplares similares
-
Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)—A Meta-analysis
por: Nasr, Christian E, et al.
Publicado: (2022) -
MON-LB097 The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier
por: Waguespack, Steven, et al.
Publicado: (2019) -
MON-525 ATA and ACR TIRADS Classification Systems as Additional Predictors of Malignancy in Afirma GSC Suspicious Thyroid Nodules
por: Azaryan, Irina, et al.
Publicado: (2020) -
THU678 Real-world Performance Of Afirma Genomic Sequencing Classifier (GSC) In A Community Healthcare Setting
por: Master, Vidisha, et al.
Publicado: (2023) -
LBSAT290 Papillary Thyroid Cancer Discovered After Benign Afirma Gene Testing, A Case Report
por: Ahmad, Mobeen, et al.
Publicado: (2022)